Watchlist Price Alert

C4 Therapeutics Inc. (CCCC)

NASDAQ: CCCC · Real-Time Price · USD

1.49

-0.05 (-3.25%)

At close: Jun 26, 2025, 11:21 AM

C4 Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-105.32M	-132.49M	-128.18M	-83.89M	-66.33M	-34.1M	-15.71M
Depreciation & Amortization	1.82M	1.88M	1.68M	1.49M	1.62M	1.59M	1.27M
Stock-Based Compensation	29.66M	27.23M	30.02M	21.51M	3.43M	1.64M	582K
Other Working Capital	-930K	3.12M	-17.69M	-25.05M	-12.2M	-3.23M	81.03M
Other Non-Cash Items	1.03M	3.48M	7.32M	2.13M	1.63M	1.14M	2.37M
Deferred Income Tax	n/a	n/a	n/a	1.88M	5.58M	350K	66K
Change in Working Capital	7.65M	-6.94M	-16.78M	-30.09M	-13.18M	84.98M	-5.56M
Operating Cash Flow	-65.16M	-106.84M	-105.94M	-86.97M	-67.25M	55.61M	-16.98M
Capital Expenditures	-180K	-1.71M	-5.5M	-1.28M	-650K	-1.35M	-2.69M
Cash Acquisitions	n/a	n/a	-63.92M	188.06M	189.85M	63K	n/a
Purchase of Investments	-284.32M	-129.9M	-219.53M	-537.74M	-293.86M	-79M	-4.99M
Sales Maturities Of Investments	233.23M	289.95M	283.44M	349.68M	104M	78.67M	44.6M
Other Investing Acitivies	n/a	n/a	63.92M	-188.06M	-189.85M	-271K	39.61M
Investing Cash Flow	-51.27M	158.35M	58.42M	-189.34M	-190.5M	-1.62M	36.92M
Debt Repayment	n/a	-12.5M	n/a	n/a	11.97M	n/a	n/a
Common Stock Repurchased	-194K	-110K	n/a	n/a	-194K	-30K	-63K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.16M	426K	1.15M	1.94M	-3.45M	274K	-63K
Financial Cash Flow	45.34M	45.49M	1.15M	171.4M	348.93M	244K	1.96M
Net Cash Flow	-71.09M	97M	-46.37M	-104.9M	91.18M	54.24M	21.9M
Free Cash Flow	-65.34M	-108.55M	-111.44M	-88.24M	-67.9M	54.27M	-19.67M